- Indexed structures
- 1
- First release
- 10 Jun 2026
- Approved drugs
- 12
Written up here
2026 – Discovery of the Orally Bioavailable Isoform Selective Janus Kinase 1 (JAK1) Compound Povorcitinib (INCB054707) for the Treatment of Inflammatory and Autoimmune Diseases
Casebook · 2 Jun 2026
All indexed structures
1 entries| Entry | Title | Method | Resolution | Released |
|---|---|---|---|---|
| 10PJ | JAK2 kinase (JH1 domain) in complex with povorcitinib | X-ray | 1.59 Å | 10 Jun 2026 |